| Literature DB >> 29289942 |
Holly Jackson1,2, Lauren A Barnett1, Kelvin P Jordan1,3, Krysia S Dziedzic1, Elizabeth Cottrell1, Andrew G Finney1, Zoe Paskins1,4, John J Edwards1.
Abstract
OBJECTIVE: To determine common patterns of recorded primary care for osteoarthritis (OA), and patient and provider characteristics associated with the quality of recorded care.Entities:
Keywords: latent class analysis; osteoarthritis; primary care; quality in health care
Mesh:
Substances:
Year: 2017 PMID: 29289942 PMCID: PMC5778330 DOI: 10.1136/bmjopen-2017-019694
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Seven quality Indicators and categories used for latent class analysis
| Quality indicator | Categories | Definition |
| 1. Pain assessed | Assessed | Recorded level of pain* |
| 2. Function assessed | Assessed | Recorded level of function* |
| 3. OA information | Given | Recorded written or verbal* |
| 4. Exercise advice | Given | Recorded written or verbal* |
| 5. Weight loss advice† | Given | Recorded written or verbal* |
| 6. Paracetamol or topical NSAID | Prescribed | Either drug prescribed‡ |
| 7. Physiotherapy | Referred | Recorded referral‡ |
*From e-template.
†Patients without a recorded BMI of ≥25 within the last 3 years were allocated to ‘Considered, but not given’ category.
‡From routine records.
BMI, body mass index; NSAID, non-steroidal anti-inflammatory drug; OA, osteoarthritis.
Latent class analysis of goodness-of-fit statistics
| Number of clusters | BIC | Χ2 goodness of fit | Population (%) of smallest cluster | Range of mean PP across clusters | n (%) with PP<0.7 |
| 1 | 20 994.14 | 32 978.08 | 1724 (100) | 1.000 | 0 (0) |
| 2 | 15 160.57 | 3332.77 | 1071 (62) | 0.992, 0.987 | 3 (<1) |
| 3 | 14 715.82 | 1727.74 | 430 (25) | 0.906, 0.991 | 138 (8) |
| 4 | 14 627.48 | 1522.28 | 184 (11) | 0.848, 0.994 | 157 (9) |
| 5 | 14 661.55 | 809.88 | 142 (8) | 0.830, 0.993 | 207 (12) |
| 6 | 14 699.79 | 733.23 | 112 (6) | 0.754, 0.996 | 257 (15) |
| 7 | 14 771.09 | 818.78 | 22 (1) | 0.701, 0.996 | 267 (15) |
BIC, Bayes information criterion; PP, posterior probabilities.
Conditional item response probabilities for the quality indicators for each cluster
| Quality indicators | Overall | Cluster | ||||
| n (%) | High (n=659, 38%) | Moderate (n=184, 11%) | Low (n=286, 17%) | None (n=595, 35%) | ||
| Pain assessment | Assessed | 1092 (63) | 0.978 | 0.961 | 0.922 | 0.014 |
| Not assessed | 632 (37) | 0.022 | 0.039 | 0.078 | 0.987 | |
| Function assessment | Assessed | 1070 (62) | 0.981 | 0.955 | 0.873 | 0.000 |
| Not assessed | 654 (38) | 0.019 | 0.045 | 0.127 | 1.000 | |
| OA information | Given | 764 (44) | 0.930 | 0.463 | 0.319 | 0.001 |
| Considered, not given | 85 (5) | 0.009 | 0.330 | 0.011 | 0.000 | |
| Not considered | 875 (51) | 0.062 | 0.207 | 0.670 | 1.000 | |
| Exercise advice | Given | 768 (45) | 0.994 | 0.417 | 0.237 | 0.000 |
| Considered, not given | 96 (6) | 0.007 | 0.313 | 0.067 | 0.000 | |
| Not considered | 860 (50) | 0.000 | 0.270 | 0.696 | 1.000 | |
| Weight advice | Given | 536 (31) | 0.593 | 0.115 | 0.089 | 0.000 |
| Considered, not given | 153 (9) | 0.298 | 0.733 | 0.347 | 0.441 | |
| Not considered | 1035 (60) | 0.109 | 0.152 | 0.564 | 0.559 | |
| Topical NSAID/paracetamol | Prescribed | 609 (35) | 0.476 | 0.273 | 0.394 | 0.239 |
| Considered, not prescribed | 570 (33) | 0.496 | 0.641 | 0.406 | 0.004 | |
| Not considered | 545 (32) | 0.028 | 0.086 | 0.200 | 0.757 | |
| Referred | 124 (7) | 0.111 | 0.037 | 0.101 | 0.032 | |
| Physiotherapy | Considered, not referred | 532 (31) | 0.559 | 0.732 | 0.080 | 0.000 |
| Not considered | 1068 (62) | 0.330 | 0.230 | 0.819 | 0.968 | |
| Median count (IQR): assessed/prescribed/given/referred | 5 (4. 6) | 3 (2. 3) | 3 (2. 3) | 0 (0. 1) | ||
| Median count (IQR): considered | 1 (1. 2) | 3 (2. 4) | 1 (0. 1) | 0 (0. 1) | ||
NSAID, non-steroidal anti-inflammatory drug; OA, osteoarthritis.
Expected number compared with observed for each category of indicators, by cluster
| Quality indicators | Cluster | ||||||||||||
| High (n=659, 38%) | Moderate (n=184, 11%) | Low (n=286, 17%) | None (n=595, 35%) | ||||||||||
| E | O | ∆ | E | O | ∆ | E | O | ∆ | E | O | ∆ | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pain assessment | Assessed (n=1092, 63%) | 645 | 645 | 0 | 177 | 177 | 0 | 264 | 263 | 1 | 8 | 7 | 1 |
|
| 14 | 14 | 0 | 7 | 7 | 0 | 22 | 23 | −1 | 587 | 588 | −1 | |
| Function assessment | Assessed (n=1070, 62%) | 646 | 646 | 0 | 176 | 174 | 2 | 250 | 250 | 0 | 0 | 0 | 0 |
|
| 13 | 13 | 0 | 8 | 10 | −2 | 36 | 36 | 0 | 595 | 595 | 0 | |
| OA information | Given (n=764, 44%) | 613 | 620 | −7 | 85 | 59 | 26 | 91 | 85 | 6 | 0 | 0 | 0 |
| Considered, | 6 | 3 | 3 | 61 | 81 | −20 | 3 | 1 | 2 | 0 | 0 | 0 | |
|
| 41 | 36 | 5 | 38 | 44 | −6 | 192 | 200 | −8 | 595 | 595 | 0 | |
| Exercise advice | Given (n=768, 45%) | 655 | 658 | −3 | 77 | 53 | 24 | 68 | 57 | 11 | 0 | 0 | 0 |
| Considered, | 4 | 1 | 3 | 58 | 77 | −19 | 19 | 18 | 1 | 0 | 0 | 0 | |
|
| 0 | 0 | 0 | 50 | 54 | −4 | 199 | 211 | −12 | 595 | 595 | 0 | |
| Weight advice | Given (n=536, 31%) | 391 | 370 | 21 | 21 | 20 | 1 | 26 | 22 | 4 | 0 | 0 | 0 |
| Considered, | 196 | 213 | −17 | 135 | 140 | −5 | 99 | 99 | 0 | 262 | 262 | 0 | |
|
| 72 | 76 | −4 | 28 | 24 | 4 | 161 | 165 | −4 | 333 | 333 | 0 | |
| Topical NSAID or paracetamol | Prescribed (n=609, 35%) | 314 | 311 | 3 | 50 | 47 | 3 | 113 | 111 | 2 | 142 | 140 | 2 |
| Considered, | 327 | 330 | −3 | 118 | 119 | −1 | 116 | 118 | −2 | 2 | 3 | −1 | |
|
| 18 | 18 | 0 | 16 | 18 | −2 | 57 | 57 | 0 | 450 | 452 | −2 | |
| Physiotherapy | Referred (n=124, 7%) | 73 | 69 | 4 | 7 | 6 | 1 | 29 | 30 | −1 | 19 | 19 | 0 |
| Considered, | 369 | 371 | −2 | 135 | 147 | −12 | 23 | 14 | 9 | 0 | 0 | 0 | |
|
| 218 | 219 | −1 | 42 | 31 | 11 | 234 | 242 | −8 | 576 | 576 | 0 | |
E, expected number; NSAID, non-steroidal anti-inflammatory drug; O, observed number; OA, osteoarthritis; ∆, difference.
Patient and clinician characteristics for each cluster
| Total n (%) | Cluster | ||||
| High (n=659) | Moderate (n=18) | Low (n =286) | None (n=595) | ||
| Patient factors | |||||
| Age | |||||
| 45–64 | 817 | 277 (34) | 109 (13) | 293 (43) | 138 (17) |
| 65–74 | 442 | 213 (48) | 20 (5) | 144 (33) | 65 (15) |
| 75–84 | 349 | 133 (38) | 35 (10) | 116 (33) | 65 (19) |
| 85+ | 116 | 36 (31) | 20 (17) | 42 (36) | 18 (6) |
| Gender | |||||
| Male | 710 | 286 (40) | 68 (10) | 113 (16) | 243 (34) |
| Female | 1014 | 373 (37) | 116 (11) | 173 (17) | 352 (35) |
| BMI category | |||||
| Normal | 315 | 111 (35) | 54 (17) | 48 (15) | 102 (32) |
| Overweight | 1080 | 471 (44) | 83 (8) | 193 (18) | 333 (31) |
| Not recorded | 329 | 77 (23) | 47 (14) | 45 (14) | 160 (49) |
| Diagnosis | |||||
| Recorded with joint pain only | 1142 | 366 (32) | 148 (13) | 207 (18) | 421 (37) |
| OA diagnosis | 582 | 293 (50) | 36 (6) | 79 (14) | 174 (30) |
| Site of OA | |||||
| Knee | 855 | 359 (42) | 80 (9) | 149 (17) | 267 (31) |
| Hip | 363 | 135 (37) | 41 (11) | 68 (19) | 119 (33) |
| Foot | 125 | 30 (24) | 15 (12) | 10 (8) | 70 (56) |
| Hand | 152 | 33 (22) | 25 (16) | 31 (20) | 63 (41) |
| Unspecified | 99 | 30 (30) | 8 (8) | 16 (16) | 45 (46) |
| Multiple | 130 | 72 (55) | 15 (12) | 12 (9) | 31 (24) |
| Morbidity load* | |||||
| BNF count | 485 | 156 (32) | 68 (14) | 89 (18) | 172 (36) |
| 5–9 | 578 | 240 (42) | 56 (10) | 99 (17) | 183 (32) |
| 10+ | 661 | 263 (40) | 60 (9) | 98 (15) | 240 (36) |
| Number of OA consultations† | |||||
| Multiple | 532 | 250 (47) | 63 (12) | 99 (19) | 120 (23) |
| Single | 1192 | 409 (34) | 121 (10) | 187 (16) | 475 (40) |
| Median (IQR) number of OA consultations† | 1 (0, 1) | 1 (1, 2) | 1 (1, 2) | 1 (1, 2) | 1 (1, 1) |
| Consulter status | |||||
| Repeat | 566 | 232 (41) | 53 (9) | 84 (15) | 197 (35) |
| New‡ | 1158 | 427 (37) | 131 (11) | 202 (17) | 398 (34) |
| Clinician factors | |||||
| Clinician OA workload† | |||||
| Below the median | 197 | 41 (21) | 16 (8) | 36 (18) | 104 (53) |
| Above the median | 1527 | 618 (41) | 168 (11) | 250 (16) | 491 (32) |
*Number of BNF subchapters from which prescription was made in previous 12 months.
†During 6-month period.
‡No clinical OA consultations within the previous 12 months.
BMI, body mass index; BNF, British National Formulary; OA, osteoarthritis.
Associations of patient and clinician characteristics with cluster membership
| n=1724 | High versus None | Moderate versus None | Low versus None |
| RRR* (95% CI) | RRR* (95% CI) | RRR* (95% CI) | |
| Patient factors | |||
| Age | |||
| 45–64 | 1 | 1 | 1 |
| 65–74 | 1.41 (1.07 to 1.84) | 0.45 (0.27 to 0.74) | 0.97 (0.69 to 1.37) |
| 75–84 | 1.13 (0.83 to 1.52) | 1.02 (0.65 to 1.60) | 1.42 (0.99 to 2.05) |
| 85+ | 0.91 (0.56 to 1.47) | 1.56 (0.85 to 2.89) | 1.24 (0.69 to 2.23) |
| Gender | |||
| Male | 1 | 1 | 1 |
| Female | 0.86 (0.69 to 1.07) | 1.03 (0.75 to 1.43) | 1.04 (0.80 to 1.36) |
| BMI category | |||
| Normal | 1 | 1 | 1 |
| Overweight | 1.20 (0.91 to 1.60) | 0.57 (0.39 to 0.85) | 1.33 (0.93 to 1.90) |
| Not recorded | 0.39 (0.27 to 0.56) | 0.52 (0.33 to 0.81) | 0.52 (0.33 to 0.82) |
| Diagnosis | |||
| Recorded with joint pain only | 1 | 1 | 1 |
| OA diagnosis | 1.81 (1.41 to 2.32) | 0.55 (0.35 to 0.85) | 0.93 (0.68 to 1.29) |
| Site of OA | |||
| Knee | 1 | 1 | 1 |
| Hip | 0.86 (0.66 to 1.14) | 1.14 (0.76 to 1.71) | 1.04 (0.75 to 1.44) |
| Foot | 0.38 (0.24 to 0.60) | 0.73 (0.39 to 1.36) | 0.25 (0.13 to 0.51) |
| Hand | 0.45 (0.30 to 0.70) | 1.18 (0.70 to 1.98) | 0.88 (0.56 to 1.39) |
| Unspecified | 0.48 (0.30 to 0.80) | 0.85 (0.38 to 1.90) | 0.74 (0.41 to 1.34) |
| Multiple | 1.13 (0.75 to 1.74) | 1.89 (0.99 to 3.59) | 0.65 (0.34 to 1.24) |
| Morbidity load† | |||
| BNF count | |||
| 0–4 | 1 | 1 | 1 |
| 5–9 | 0.95 (0.71 to 1.26) | 0.74 (0.50 to 1.11) | 0.75 (0.54 to 1.06) |
| 10+ | 0.64 (0.47 to 0.87) | 0.55 (0.35 to 0.86) | 0.50 (0.35 to 0.73) |
| Number of OA consultations‡ | |||
| Multiple | 1 | 1 | 1 |
| Single | 0.43 (0.34 to 0.54) | 0.47 (0.33 to 0.66) | 0.45 (0.34 to 0.60) |
| Consulter status | |||
| Repeat | 1 | 1 | 1 |
| New§ | 1.12 (0.89 to 1.41) | 1.09 (0.76 to 1.55) | 1.18 (0.88 to 1.59) |
| Clinician factors | |||
| Clinician OA workload‡ | |||
| Below the median | 1 | 1 | 1 |
| Above the median | 2.90 (1.98 to 4.25) | 2.32 (1.33 to 4.03) | 1.46 (0.98 to 2.18) |
*Relative risk ratio from multilevel multinomial regression (patients within initial clinician seen) adjusted for all presented covariates, None cluster is reference.
†Number of BNF subchapters from which prescription was made in previous 12 months.
‡During 6-month period.
§No clinical OA consultations within the previous 12 months.
BMI, body mass index; BNF, British National Formulary; OA, osteoarthritis; RRR, relative risk ratios.
Use of management processes other than those used as quality indicators, and recorded severity of pain and functional limitation, by cluster
| n (column %) | Total n (%) | Cluster | P value* | |||
| High (n=659) | Moderate (n=184) | Low (n=286) | None (n=595) | |||
| Opioid prescribed | 557 (33) | 236 (36) | 54 (29) | 94 (33) | 173 (29) | 0.06 |
| Oral NSAID prescribed | 284 (17) | 130 (20) | 21 (11) | 49 (17) | 84 (14) | 0.01 |
| X-ray requested | 263 (15) | 142 (22) | 30 (16) | 52 (18) | 39 (7) | <0.01 |
| n with pain record | 1092 | 645 | 177 | 263 | 7 | 0.001† |
| No pain | 16 (1) | 4 (<1) | 7 (4) | 4 (2) | 1 | |
| Mild pain | 348 (32) | 187 (29) | 69 (39) | 91 (35) | 1 | |
| Moderate pain | 582 (53) | 357 (55) | 84 (47) | 136 (52) | 5 | |
| Severe pain | 146 (13) | 97 (15) | 17 (10) | 32 (12) | 0 | |
| n with function record | 1070 | 646 | 174 | 250 | 0 | 0.004† |
| No limitation | 101 (9) | 46 (7) | 29 (16) | 26 (10) | 0 | |
| Mild limitation | 456 (43) | 276 (43) | 73 (42) | 107 (43) | 0 | |
| Moderate limitation | 427 (40) | 277 (43) | 57 (33) | 93 (37) | 0 | |
| Severe limitation | 86 (8) | 47 (7) | 15 (9) | 24 (10) | 0 | |
*χ2 test.
†Excluding None cluster.
NSAID, non-steroidal anti-inflammatory drug.